Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Schrieks, Ilse C; Nozza, Anna; Stähli, Barbara E; Buse, John B; Henry, Robert R; Malmberg, Klas; Neal, Bruce; Nicholls, Stephen J; Rydén, Lars; Mellbin, Linda; Svensson, Anders; Wedel, Hans; Weichert, Arlette; Lincoff, A Michael; Tardif, Jean-Claude; Grobbee, Diederick E; Schwartz, Gregory G (2018). Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome. Diabetes Care, 41(8):1792-1800.

Stähli, Barbara E; Nozza, Anna; Schrieks, Ilse C; Buse, John B; Malmberg, Klas; Mellbin, Linda; Neal, Bruce; Nicholls, Stephen J; Rydén, Lars; Svensson, Anders; Wedel, Hans; Weichert, Arlette; Lincoff, A Michael; Grobbee, Diederick E; Tardif, Jean-Claude; Schwartz, Gregory G (2018). Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome. Journal of Clinical Endocrinology & Metabolism, 103(7):2522-2533.

MacDonald, Thomas M; Hawkey, Chris J; Ford, Ian; McMurray, John J V; Scheiman, James M; Hallas, Jesper; Findlay, Evelyn; Grobbee, Diederick E; Hobbs, F D Richard; Ralston, Stuart H; Reid, David M; Walters, Matthew R; Webster, John; Ruschitzka, Frank; Ritchie, Lewis D; Perez-Gutthann, Susana; Connolly, Eugene; Greenlaw, Nicola; Wilson, Adam; Wei, Li; Mackenzie, Isla S (2017). Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). European Heart Journal, 38(23):1843-1850.

This list was generated on Mon Sep 16 02:49:04 2019 CEST.